February 20, 2018
1 min read

Johnson & Johnson Medical Devices Companies acquires Orthotaxy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Johnson & Johnson Medical Devices Companies announced its acquisition of Orthotaxy, a privately held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution.

The technology is in early-stage development for total and partial knee replacement, and Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of orthopedic surgery procedures, according to a company press release. With the goal to build a next-generation robotic-assisted orthopedic surgery solution that is cost-effective, time-efficient and user-friendly in a variety of care settings, Orthotaxy’s technology will reportedly be a critical part of a complete orthopedic solution that uses enabling technologies to personalize procedures, optimize surgery and bring value to customers and patients.

The release also noted Johnson & Johnson Medical Devices Companies plan to focus on digital technology solutions that expand beyond providing best-in-class products to transformative solutions across the full continuum of care in the future.

“Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopedics platform, delivering value to patients, physicians and health care providers across the episode of care,” Ciro RΓΆmer, company group chairman of DePuy Synthes, the orthopedics business of Johnson & Johnson, said in the release. “The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction.”